Different Levels of Immunogenicity of Two Strains of Fowlpox Virus as Recombinant Vaccine Vectors Eliciting T-Cell Responses in Heterologous Prime-Boost Vaccination StrategiesMatthew G. Cottingham, Michael A. Skinner, Richard J. Anderson et al.|Clinical and Vaccine Immunology|2006Cited by 18
Identification and characterisation of the dose response of otelixizumab in new onset type 1 diabetes patientsAntonio Napolitano, Bart Keymeulen, André van Maurik et al.|VUBIR (Vrije Universiteit Brussel)|2019Cited by 0